Sanford Advisory Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$359K Buy
1,368
+42
+3% +$11.3K 0.09% 103
2022
Q3
$299K Hold
1,326
0.09% 91
2022
Q2
$322K Hold
1,326
0.09% 87
2022
Q1
$321K Buy
1,326
+77
+6% +$17.7K 0.09% 83
2021
Q4
$281K Sell
1,249
-12
-1% -$2.53K 0.06% 92
2021
Q3
$268K Hold
1,261
0.07% 92
2021
Q2
$307K Hold
1,261
0.08% 85
2021
Q1
$314K Hold
1,261
0.09% 82
2020
Q4
$290K Buy
+1,261
New +$291K 0.09% 78

Other funds holding AMGN

Sanford Advisory Services's AMGN Position: Q4 2022 in Review

Sanford Advisory Services increased its Amgen (AMGN) stake by 3.2% in Q4 2022, buying an estimated $11.3K and bringing the position to 1,368 shares worth $359K. The position accounts for 0.09% of the portfolio, ranked #103.

Sanford Advisory Services first reported a position in AMGN in Q4 2020 and has held it in 9 quarters since. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Sanford Advisory Services held 1,368 shares of Amgen worth $359K as of Q4 2022.
  • Sanford Advisory Services bought 42 Amgen shares in Q4 2022, an estimated $11.3K.
  • Amgen made up 0.09% of Sanford Advisory Services's portfolio in Q4 2022, its #103 holding.
  • Sanford Advisory Services first reported a position in Amgen in Q4 2020 and has held it in 9 quarters since.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Sanford Advisory Services's 13F filing for Q4 2022, filed 8 Feb 2023.